Completed OBSERVATIONAL NCT04274751

Comparison of Transaxillary and Transfemoral Fully-percutaneous Approaches for Transcatheter Aortic Valve Implantation (TRANSAX)

Comparison of Transaxillary and Transfemoral Fully-percutaneous Approaches for Transcatheter Aortic Valve Implantation: The TRANSAX Study

Sponsor: Boston Scientific Corporation

Conditions Aortic Valve Stenosis

Interventions Transcatheter aortic valve implantation

Updated 5 times since 2020 Last updated: Oct 18, 2021 Started: Jul 1, 2019 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Aortic Valve Stenosis and is currently completed. Boston Scientific Corporation leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Nov 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Nov 2021 [monthly]

Recruiting
Mar 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Jul 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Scientific Corporation
Ignacio J. Amat Santos

Data source: Hospital Clínico Universitario de Valladolid

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valladolid, Spain